- A new Westlake-backed biotech takes aim at migraines<p>Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing “anti-PACAP” therapies, an increasingly popular strategy for migraine prevent…BioPharma Dive · 1mo ago↗ source
- Opinion: As a physician, I have never been more concerned about rates of congenital syphilis“As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.STAT · 1mo ago↗ source
- Opinion: The quiet joy of being an oncologist“The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…STAT